Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
A. Glencer, K. Ramalingam, N. Schindler, H. Mori, P. Ghule, K. C. Lee, D. Nachmanson, A. Officer, O. Harismendy, J. L. Stein, G. Stein, D. Weaver, C. Yau, G. L. Hirst, M. J. Campbell, , A. D. Borowsky
This study identifies immune microenvironment features and myoepithelial continuity as key determinants of progression in high-risk DCIS.
bioRxiv · Dec 1, 2023 · PreprintCancer Biology
A. Semaan, V. Bernard, J. Wong, Y. Makino, D. Swartzlander, K. I. Rajapakshe, J. Lee, A. Officer, C. M. Schmidt, H. H. Wu, C. L. Scaife, K. E. Affolter, D. Nachmanson, M. A. Firpo, M. Yip-Schneider, , P. A. Guerrero
This study integrates genomic and transcriptomic analysis of intraductal papillary mucinous neoplasms (IPMNs) to identify molecular features associated with progression to high-grade lesions and cancer.
bioRxiv · Oct 14, 2022 · PreprintCancer Biology
A. Officer, A. M. Dempsey, L. M. Murrow, Z. Gartner, P. Tamayo, C. Yau, O. Harismendy
This study identifies changes in stromal-epithelial interactions between in situ and invasive breast cancer using gene expression profiling, finding significant ligand-receptor pairs associated with prognosis.
bioRxiv · Jul 30, 2022 · PreprintCancer Biology
A. Papadas, G. Deb, A. Officer, A. Cicala, C. Hope, P. Emmerich, J. Wiesner, A. Pagenkopf, G. Arauz, V. Bansal, K. Matkowskyj, D. A. Deming, K. Politi, S. Abrams, O. Harismendy, F. Asimakopoulos
The paper shows that stromal remodeling generates signals that regulate dendritic cell survival and activity, enhancing T-cell inflammation in the tumor microenvironment.
bioRxiv · Nov 10, 2021Immunology
M. Pagadala, V. H. Wu, E. Perez-Guijarro, H. Kim, A. Castro, J. Talwar, T. Sears, C. Gonzalez-Colin, S. Cao, B. Schmiedel, S. Goudarzi, D. Kirani, R. Salem, G. Morris, O. Harismendy, , H. Carter
The paper identifies germline variants associated with the tumor immune microenvironment, linking them to cancer risk and immunotherapy response.
bioRxiv · Apr 14, 2021 · PreprintCancer Biology
A. T. Wenzel, D. Champa, H. Venkatesh, S. Sun, C.-Y. Tsai, J. P. Mesirov, J. D. Bui, S. B. Howell, O. Harismendy
The paper characterizes the step-wise acquisition of carboplatin resistance in ovarian cancer using single-cell gene expression analysis and identifies distinct transcriptional patterns associated with resistance.
bioRxiv · Feb 7, 2021Cancer Biology